Med-U-Way Lecture Series

The Appropriate Use of Immunosuppressive Therapies in Rheumatology
Drs. Marcy Bolster and Jim Oates
March 2007

Objectives

The information presented during this educational activity should improve your ability to

  • Describe the benefits and risks of immunosuppressive therapies in patients with rheumatoid arthritis (RA) and systematic lupus erythematosus (SLE).
  • Discuss the appropriate monitoring for potential toxicities for the immunosuppressive therapies used in RA and SLE.

Disclosure

Dr. Bolster: Advisory Board/Committee member, Abbott Scholar Committee; Speaker's Bureau, Genentech and Merck; Research Grant, Procter and Gamble; and Clinical Research Trial, Genentech.

Dr. Oates: Consultant, Genentech and Schering Plough.